Epilepsy in India, Pg10

Key Highlights:

• India has over 10 million people affected by epilepsy, with significant treatment gaps between rural and urban areas.
• Treatment gaps range from 22 to 95 percent, disproportionately affecting women and low-income groups.
• Secondary treatment dropout reaches 25.8 percent due to medication expenses and stigma.
• Nearly 80 percent of epilepsy care is privately financed, leading to high out-of-pocket expenses.

Detailed Insights:

• Limited access to specialists, interrupted drug supplies, and high transport costs contribute to poor adherence to epilepsy treatment.
• Poor adherence reduces the quality of life, especially among married women over 30 years old, impacting physical and psychological well-being.
• Economic strain disrupts care, reduces employability, and leads to poorer health outcomes for epilepsy patients.
• Systemic actions such as training primary care providers, expanding tele-neurology, and strengthening referral networks are needed to improve continuity of care.
• Public awareness campaigns, patient education, mobile apps, and pill reminders can enhance adherence to medication.
• Multidisciplinary care models and public-private partnerships can deliver equitable access and sustained seizure control.

Key Concepts Involved:

• Epilepsy: A chronic neurological disorder characterized by recurrent seizures.
• Tele-neurology: The use of technology to provide neurological care remotely.
• Stigma: A negative perception or discrimination against individuals with a particular condition.